Pages that link to "Q46781779"
Jump to navigation
Jump to search
The following pages link to Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study (Q46781779):
Displaying 50 items.
- Pre-chemotherapy differences in visuospatial working memory in breast cancer patients compared to controls: an FMRI study (Q21129407) (← links)
- Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system (Q21146752) (← links)
- Cancer- and cancer treatment-associated cognitive change: an update on the state of the science (Q26853289) (← links)
- Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy (Q28275971) (← links)
- Cognitive function in breast cancer survivors compared to healthy age- and education-matched women (Q30458869) (← links)
- Opening up the window into "chemobrain": a neuroimaging review (Q30596880) (← links)
- Recovery from chemotherapy-induced white matter changes in young breast cancer survivors? (Q31155370) (← links)
- Prolonged impact of chemotherapy on fatigue in breast cancer survivors: a longitudinal comparison with radiotherapy-treated breast cancer survivors and noncancer controls (Q33557644) (← links)
- Altered cerebral blood flow one month after systemic chemotherapy for breast cancer: a prospective study using pulsed arterial spin labeling MRI perfusion (Q33590378) (← links)
- The Working Memory and Dorsolateral Prefrontal-Hippocampal Functional Connectivity Changes in Long-Term Survival Breast Cancer Patients Treated with Tamoxifen (Q33636517) (← links)
- Factors associated with cancer-related fatigue in breast cancer patients undergoing endocrine therapy in an urban setting: a cross-sectional study (Q33669605) (← links)
- What do perceived cognitive problems reflect? (Q33707551) (← links)
- Prevalence, mechanisms, and management of cancer-related cognitive impairment (Q33854977) (← links)
- Asiatic acid protects against cognitive deficits and reductions in cell proliferation and survival in the rat hippocampus caused by 5-fluorouracil chemotherapy. (Q33888300) (← links)
- A prospective study of grey matter and cognitive function alterations in chemotherapy-treated breast cancer patients. (Q34110937) (← links)
- Predictors and course of chronic fatigue in long-term breast cancer survivors (Q34297994) (← links)
- Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. (Q34395112) (← links)
- Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients (Q34587999) (← links)
- Behavioral symptoms in patients with breast cancer and survivors (Q34675620) (← links)
- Cognitive function in breast cancer patients prior to adjuvant treatment (Q35043593) (← links)
- Is symptom-oriented follow-up still up to date? (Q35084969) (← links)
- Preserved learning and memory following 5-fluorouracil and cyclophosphamide treatment in rats (Q35243657) (← links)
- Biomarkers of fatigue related to adjuvant chemotherapy for breast cancer: evaluation of plasma and lymphocyte expression (Q35264807) (← links)
- Long-term cognitive impairment in older adult twins discordant for gynecologic cancer treatment (Q35535907) (← links)
- Can physical activity help to maintain cognitive functioning and psychosocial well-being among breast cancer patients treated with chemotherapy? A randomised controlled trial: study protocol (Q35611921) (← links)
- Cognitive functioning after cancer treatment: a 3-year longitudinal comparison of breast cancer survivors treated with chemotherapy or radiation and noncancer controls. (Q35834672) (← links)
- Patterns of change in cognitive function with anastrozole therapy. (Q35883135) (← links)
- Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer (Q35949546) (← links)
- Effect of exercise in reducing breast and chest-wall pain in patients with breast cancer: a pilot study (Q36000235) (← links)
- Long-term cognitive function change among breast cancer survivors (Q36057049) (← links)
- Interventions to Alleviate Symptoms Related to Breast Cancer Treatments and Areas of Needed Research (Q36127633) (← links)
- Topological Organization of Metabolic Brain Networks in Pre-Chemotherapy Cancer with Depression: A Resting-State PET Study (Q36188728) (← links)
- Quality of life over time in women diagnosed with ductal carcinoma in situ, early-stage invasive breast cancer, and age-matched controls. (Q36251684) (← links)
- Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer. (Q36608806) (← links)
- Prevalence of fatigue among cancer patients receiving various anticancer therapies and its impact on quality of life: a cross-sectional study (Q36612753) (← links)
- Impact on quality of life of adjuvant therapy for breast cancer (Q36681512) (← links)
- A comparison of cognitive function, sleep and activity levels in disease-free breast cancer patients with or without cancer-related fatigue syndrome (Q36753035) (← links)
- Acupuncture for chemotherapy-associated cognitive dysfunction: a hypothesis-generating literature review to inform clinical advice (Q36757041) (← links)
- Cytokine genetic variations and fatigue among patients with breast cancer (Q36793285) (← links)
- Multivariate analysis of brain metabolism reveals chemotherapy effects on prefrontal cerebellar system when related to dorsal attention network (Q36797484) (← links)
- Factors affecting cancer survivors' employment and work ability (Q36819556) (← links)
- Quantifying fatigue in (long-term) colorectal cancer survivors: a study from the population-based patient reported outcomes following initial treatment and long term evaluation of survivorship registry (Q36914037) (← links)
- The relationship of cognitive performance to concurrent symptoms, cancer- and cancer-treatment-related variables in women with early-stage breast cancer: a 2-year longitudinal study. (Q36989543) (← links)
- Quality of life and adjuvant systemic therapy for early-stage breast cancer (Q37008863) (← links)
- Cognitive functioning in breast cancer survivors: a controlled comparison (Q37157773) (← links)
- Brain vulnerability to chemotherapy toxicities (Q37211338) (← links)
- Postoperative hormonal therapy prevents recovery of neurological damage after surgery in patients with breast cancer (Q37314706) (← links)
- Effects of tamoxifen and raloxifene on memory and other cognitive abilities: cognition in the study of tamoxifen and raloxifene (Q37412283) (← links)
- One-year outcomes of a behavioral therapy intervention trial on sleep quality and cancer-related fatigue (Q37474421) (← links)
- Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907. (Q37576583) (← links)